Published in Vaccine Weekly, July 13th, 2005
The report details how the pending Central American Free Trade Agreement (CAFTA) and other trade agreements such as NAFTA derail access to affordable generic medications in Latin and Central America and other developing world countries, including access to life-saving anti-retroviral therapies (ARVs) for HIV/AIDS treatment.
"As a provider of medical care and anti-retroviral AIDS treatment in Mexico, we are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.